All Type of News
Tritace Protect expanding presence in cardiovascular market
Handok Pharm said on March 16 that its Tritace Protect (ramipril) 10mg tablet has been expanding their presence in the domestic cardiovascular market since its launching on March of Last year.
Tritace Protect has b...
Korea's drug spending lowest in advanced countries
Koreans were found to have spent the least on drugs among advanced countries.
The country's drug expenditure was equivalent to 1.53 percent of its gross domestic product (GDP) in 2004, the lowest among advanced cou...
Will junior Kang be winner over senior Kang in Dong-A?
Kang Moon-seok, the son of Dong-A Pharmaceutical Chairman Kang Shin-ho, will face a bumpy road for his comeback to Korea's largest drug maker, as a prominent shareholder of the company, in the midst of its employees' ...
Survey found physician's original drug prescriptions for efficacy reasons.
A survey conducted by Prof. Lee Kyu-shik of Yonsei Univ. Public Health School reported under the title of "An opinion survey on the drug price optimization" that after the medical reform program physicians prescribed ...
Boryung's self medication projects impressive.
Boryung announced on Jan. 1 this year that the OTC marketing division was renamed to the SM (self medication) division. Since then 2 month short term business performance of OTC products made a satisfactory achievemen...
ISU ABXIS to release first antibodytherapeuticISU ABXIS Inc., a local biotechnology specialized in developing and manufacturing therapeutic antibodies, said it will launch its first antibody therapeutic Clotinab (anti-GP II...
|
Three medical workers protest medical reform
Three medical organizations - The Korea Medical Association, the Association of Korean Oriental Medicine, and the Korean Hospital Association will vow to protest the government-led revision of an old medical law, acc...
Handok to sell Amaryl-M firstly to overseas market in March.Handok plans to supply Amaryl-M, an anti-hyperglycemic drug developed by Handok Central Research Institute, to the overseas markets from coming March this year, mainly to Peru f...
|
"Atacand Plus" monotherapy effective for new hypertensive patients.A study for 5,543 patients with high blood pressure in 5 major cities including Seoul, Busan, Daegu, Daejeon and Guangju who visited to private clinics reported that Atacand Plu...
|
Domestic insecticide makers eye new natural products
Daewoong Pharm, Chong Kung Dang Pharmaceutical and Samsung Pharm plan to develop natural insecticides to be priced at more than 1,500 won, as the Korea Food and Drug Administration banned production and sales of 41 in...
